retatrutide clinical trial results 2024 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Medscape | Retatrutide, Eli Lilly's
Pay in 4 interest-free payments of $5.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27




















![APR Slash-Cut Exhaust Tips E82 · E88 135i 3.0L Turbo I6 [N55]](https://cdn.shopify.com/s/files/1/0635/0032/1015/files/APRSlash-CutExhaustTips.png?v=1686594407)




